Wednesday, February 18, 2026 | 05:00 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aurobindo Pharma Ltd Quarterly Results

Q3 FY25-26 Results Summary

Revenue

The revenue stands at ₹8,645.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.35 per cent from ₹8,285.70 crore. This corresponds to a year-on-year *(YoY) growth of 8.36 per cent.

Operating Profit

Operating Profit stands at ₹280.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.10 per cent from ₹217.49 crore. This corresponds to a year-on-year *(YoY) growth of 1.23 per cent.

PBDT

PBDT stands at ₹893.45 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.26 per cent from ₹856.98 crore. This corresponds to a year-on-year *(YoY) growth of 15.61 per cent.

Profit Before Tax

Profit Before Tax stands at ₹1,338.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.91 per cent from ₹1,275.92 crore. This corresponds to a year-on-year *(YoY) growth of 11.56 per cent.

Net Profit

Net Profit stands at ₹975.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.99 per cent from ₹848.45 crore. This represents a 15.35 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Aurobindo Pharma Ltd Earnings

Data not available

Aurobindo Pharma Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Aurobindo Pharma Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 1,430Motilal Oswal04-Dec-2025
Buy 1,460Edelweiss Securities20-Jun-2025
Buy 1,387JM Financial28-May-2025
Buy 1,370Motilal Oswal28-May-2025
Buy 1,677Edelweiss Securities12-Nov-2024

Aurobindo Pharma Ltd Financial Reports

Filter By:
Loading...

Aurobindo Pharma Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Aurobindo Pharma-0.84%1.18%0.34%-5.01%7.42%3.07%
Lupin-0.77%0.62%2.09%9.81%12.99%12.48%
Zydus Lifesci.0.36%-1.17%3.29%-2.19%-7.98%2.09%
Mankind Pharma0.35%-0.33%-2.16%-6.80%-16.84%-12.34%
Alkem Lab0.42%-6.74%-4.85%-4.70%1.37%15.20%
Biocon-0.18%0.95%0.74%-7.58%4.07%12.50%
Glenmark Pharma.-0.13%-0.45%1.73%10.04%4.06%47.87%

Company Info

Company Information

Vice Chairman & Managing Director : Kambam Nityananda Reddy

Whole-time Director : M Madan Mohan Reddy

Non Executive Director : P V Ramprasad Reddy

Independent Director : Girish Paman Vanvari

Non Executive Director : P Sarath Chandra Reddy

Independent Director : Santanu Mukherjee

Chairman & Independent Director : M R Kumar

Non Executive Director : Satakarni Makkapati

Company Sec. & Compli. Officer : B Adi Reddy

Additional Director : Punita Kumar Sinha

Aurobindo Pharma Ltd News

Data Not Available